← Back to Search

Specialized Employment Program for Autism

N/A
Recruiting
Led By Lawrence Fung, MD, PhD
Research Sponsored by Lawrence Fung
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18-55
Able to travel to work independently
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at screening, 3 months after onboarding at job position, 6 months after onboarding, 12 months after onboarding, 15 months after onboarding, 18 months after onboarding.
Awards & highlights
No Placebo-Only Group

Summary

This trial will examine whether the Neurodiversity at Work Program at Stanford University improves employment outcomes for adults with autism spectrum disorder.

Who is the study for?
This trial is for adults aged 18-55 with Autism Spectrum Disorder (ASD) who can travel to work on their own. They should have completed an internship, pre-employment training, or both and must have a college degree. Participants need to have an IQ within the range of 60 and above, without significant current psychosocial stressors.
What is being tested?
The study tests the effectiveness of Stanford University's Neurodiversity at Work (NaW) Program compared to traditional vocational support. It aims to see if NaW helps adults with ASD maintain steady jobs and improve their quality of life.
What are the potential side effects?
Since this trial involves employment support programs rather than medical interventions, there are no direct side effects like those associated with medications or clinical treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 55 years old.
Select...
I can travel to work on my own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at screening, 3 months after onboarding at job position, 6 months after onboarding, 12 months after onboarding, 15 months after onboarding, 18 months after onboarding.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at screening, 3 months after onboarding at job position, 6 months after onboarding, 12 months after onboarding, 15 months after onboarding, 18 months after onboarding. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Costs of Employee Turnover
Duration of Sustained Employment
Job Retention Rates
+2 more
Secondary study objectives
ANZ Financial Well-being Scale
Eisenberger's Perceived Organizational Support
Judge's Global Job Satisfaction
+5 more
Other study objectives
Autism Spectrum Quotient
Patient Health Questionnaire (PHQ-9)
Rosenberg Scale of Self-Esteem
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Neurodiversity at Work - Delayed Start (NaW-DS)Experimental Treatment1 Intervention
Participants in this group will receive typical orientation for neurotypical employees after onboarding. The support of peer mentor, job/life skills coach, vocational rehabilitation counselor, and a personal counselor will start 6 months after onboarding. Managers, co-workers, team buddies and mentors for all recruited and hired employees in both groups will receive the same specialized training to enhance their abilities to work with individuals with ASD.
Group II: Neurodiversity at Work (NaW) GroupExperimental Treatment1 Intervention
Individuals in this group will receive a 6-week Autism at Work pre-employment training. Upon onboarding, each individual will be supported by a team manager, a team buddy, a peer mentor, a job/life skills coach, a vocational rehabilitation counselor, and a personal counselor. Ongoing support for members of support circles will be provided during the 12 weeks immediately after onboarding.

Find a Location

Who is running the clinical trial?

Rangam ConsultantsUNKNOWN
3R Behavioral SolutionsUNKNOWN
Lawrence FungLead Sponsor
Lawrence Fung, MD, PhDPrincipal Investigator - Stanford University
Stanford University
1 Previous Clinical Trials
1 Trials studying Autism Spectrum Disorder

Media Library

NaW Clinical Trial Eligibility Overview. Trial Name: NCT04107064 — N/A
Autism Spectrum Disorder Research Study Groups: Neurodiversity at Work (NaW) Group, Neurodiversity at Work - Delayed Start (NaW-DS)
Autism Spectrum Disorder Clinical Trial 2023: NaW Highlights & Side Effects. Trial Name: NCT04107064 — N/A
NaW 2023 Treatment Timeline for Medical Study. Trial Name: NCT04107064 — N/A
~12 spots leftby Dec 2025